RecruitingNot ApplicableNCT06445933

Vitamin B6 and Depression in Pregnant and Peri-partum Women

The Correlation Between Vitamin B6 and Avoiding Depression in Pregnant and Peri-partum Women


Sponsor

National Taiwan University Hospital

Enrollment

150 participants

Start Date

Jul 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Perinatal depression is a highly prevalent and serious health issue during pregnancy. According to statistics, approximately one out of every ten postpartum women experiences this condition. Symptoms can manifest as mood fluctuations or emotional lows. Unfortunately, these symptoms are often overlooked by patients themselves or misinterpreted by others as normal adjustments to the new role of motherhood. Consequently, timely assistance and support are frequently lacking. To address this, the investigators urgently need effective preventive measures for perinatal depression before it escalates. Recent research suggests that simple oral supplementation of vitamin B6 may help prevent and alleviate perinatal depression to some extent. Vitamin B6 plays several crucial roles in the body, including regulating neurotransmission and mental health. Therefore, it could contribute to maintaining emotional stability and psychological balance. In contemporary times, numerous screening methods for perinatal depression involve questionnaires. However, these methods presuppose an awareness of the possibility of perinatal depression. Individuals who are unaware of these questionnaires may go undetected. Hence, our aim is to investigate whether cardiac electrophysiology results obtained through a wearable device could offer a more objective evaluation of the status of perinatal depression. Our plan involves conducting a prospective study to delve deeper into the preventive and therapeutic effects of vitamin B6 on perinatal depression in pregnant women. Through systematic experiments and data analysis, the investigators aim to explore the impact of vitamin B6 dosage, duration, and timing of administration. Ultimately, the investigators hope to provide evidence-based recommendations and guidance for clinical practice. The investigators' goal is to offer new insights and methods to protect the mental health of expectant mothers, ensuring a pleasant and healthy pregnancy journey for each one.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether taking vitamin B6 supplements during pregnancy can help prevent or reduce depression in pregnant women and new mothers (the period around childbirth). Low vitamin B6 has been linked to mood changes, and this trial tests whether correcting that may help. **You may be eligible if...** - You are pregnant and between 24 and 28 weeks of gestation - You have no personal history of depression, bipolar disorder, schizophrenia, or other mental health conditions **You may NOT be eligible if...** - You are allergic to vitamin B6 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTVitamin B6

The intervention is taking Vitamin B6 orally from recruitment around 24-28 gestational weeks to 6 weeks post-partum. 75mg/ day before delivery and 50mg/ day after delivery.

COMBINATION_PRODUCTPlacebo

Placebo


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06445933


Related Trials